Next Article in Journal
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
Previous Article in Journal
Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples
 
 
Article

Design of a Multiepitope Vaccine against Chicken Anemia Virus Disease

1
Discipline of Genetics, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, P/Bag X54001, Durban 4000, South Africa
2
Department of Chemical Engineering, Mangosuthu University of Technology, Umlazi, Durban 4031, South Africa
3
Department of Industrial Chemistry, Federal University, Oye-Ekiti P.O. Box 370111, Nigeria
4
Department of Chemistry, University of the Free State, P.O. Box 339, Bloemfontein 9300, South Africa
*
Authors to whom correspondence should be addressed.
Academic Editor: Hualan Chen
Viruses 2022, 14(7), 1456; https://doi.org/10.3390/v14071456
Received: 28 April 2022 / Revised: 22 June 2022 / Accepted: 24 June 2022 / Published: 30 June 2022
(This article belongs to the Section Animal Viruses)
Chicken anemia virus (CAV) causes severe clinical and sub-clinical infection in poultry globally and thus leads to economic losses. The drawbacks of the commercially available vaccines against CAV disease signal the need for a novel, safe, and effective vaccine design. In this study, a multiepitope vaccine (MEV) consisting of T-cell and B-cell epitopes from CAV viral proteins (VP1 and VP2) was computationally constructed with the help of linkers and adjuvant. The 3D model of the MEV construct was refined and validated by different online bioinformatics tools. Molecular docking showed stable interaction of the MEV construct with TLR3, and this was confirmed by Molecular Dynamics Simulation. Codon optimization and in silico cloning of the vaccine in pET-28a (+) vector also showed its potential expression in the E. coli K12 system. The immune simulation also indicated the ability of this vaccine to induce an effective immune response against this virus. Although the vaccine in this study was computationally constructed and still requires further in vivo study to confirm its effectiveness, this study marks a very important step towards designing a potential vaccine against CAV disease. View Full-Text
Keywords: chicken anemia virus; disease; immunoinformatics; immune response; multiepitope; viral proteins chicken anemia virus; disease; immunoinformatics; immune response; multiepitope; viral proteins
Show Figures

Figure 1

MDPI and ACS Style

Fatoba, A.J.; Adeleke, V.T.; Maharaj, L.; Okpeku, M.; Adeniyi, A.A.; Adeleke, M.A. Design of a Multiepitope Vaccine against Chicken Anemia Virus Disease. Viruses 2022, 14, 1456. https://doi.org/10.3390/v14071456

AMA Style

Fatoba AJ, Adeleke VT, Maharaj L, Okpeku M, Adeniyi AA, Adeleke MA. Design of a Multiepitope Vaccine against Chicken Anemia Virus Disease. Viruses. 2022; 14(7):1456. https://doi.org/10.3390/v14071456

Chicago/Turabian Style

Fatoba, Abiodun Joseph, Victoria T. Adeleke, Leah Maharaj, Moses Okpeku, Adebayo A. Adeniyi, and Matthew A. Adeleke. 2022. "Design of a Multiepitope Vaccine against Chicken Anemia Virus Disease" Viruses 14, no. 7: 1456. https://doi.org/10.3390/v14071456

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop